Genetic background and tumour susceptibility in mouse models

Cell Death and Differentiation

Volumn 20, Issue 7, 2013, Pages 964-

  Puccini, J ^a,b   Dorstyn, L ^a,b,c   Kumar, S ^a,b,c  

^a Centre for Cancer Biology SA Pathology   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SUSCEPTIBILITY; CELL DEATH; CELL DIFFERENTIATION; CROSS BREEDING; GENOTYPE; LETTER; NONHUMAN; ONCOGENE; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; LEUKEMIA, T-CELL; MALE; PROTEIN-SERINE-THREONINE KINASES; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEINS;

EID: 84880271881     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.35     Document Type: Letter

References (9)

1. Rivera J et al. Immunity 2008; 28: 1-4.
2. Doetschman T. Methods Mol Biol 2009; 530: 423-433.
3. Biswas S et al. Cell Death Differ 2013; 20: 869-877.
4. Klopstock N et al. PLoS One 2009; 4: e5025.
5. Weiss WA et al. EMBO J 1997; 16: 2985-2995.
6. Donehower LA et al. Mol Carcinog 1995; 14: 16-22.
7. Petiniot LK et al. Mol Cell Biol 2002; 22: 3174-3177.
8. Reliene R et al. DNA Repair 2006; 5: 651-653.
9. Valdar W et al. Genetics 2006; 174: 959-984.